|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 12 studies with search of: | Intussusception |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Intussusception Surveillance After Rotarix Introduction in Mexico
|
||||
| 2 | Recruiting |
Stapled TransAnal Rectal Resection (STARR) With Contour® TranstarTM
|
||||
| 3 | Completed |
Implementing Hospital-Based Active Surveillance Procedures for Vaccine Safety Monitoring at IMSS Hospitals in Mexico
|
||||
| 4 | Completed |
RCT: STARR vs Biofeedback
|
||||
| 5 | Completed |
Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)
|
||||
| 6 | Recruiting |
Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States
|
||||
| 7 | Recruiting |
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome: A Pilot Study
|
||||
| 8 | Active, not recruiting |
Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old
|
||||
| 9 | Completed |
Long-Term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.
|
||||
| 10 | Completed |
Consistency Lots Vaccine Study
|
||||
| 11 | Completed |
A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants.
|
||||
| 12 | Completed |
A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.
|